Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D03KAQ
|
||||
| Former ID |
DNC010088
|
||||
| Drug Name |
2-Benzylaminomethyl-3-hydroxymorphinan
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530529] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C25H32N2O
|
||||
| Canonical SMILES |
CN1CCC23CCCCC2C1CC4=CC(=C(C=C34)O)CNCC5=CC=CC=C5
|
||||
| InChI |
1S/C25H32N2O/c1-27-12-11-25-10-6-5-9-21(25)23(27)14-19-13-20(24(28)15-22(19)25)17-26-16-18-7-3-2-4-8-18/h2-4,7-8,13,15,21,23,26,28H,5-6,9-12,14,16-17H2,1H3/t21-,23+,25+/m0/s1
|
||||
| InChIKey |
BGGKLNVUQJUZIE-QQKQFIJSSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Kappa-type opioid receptor | Target Info | Inhibitor | [530529] | |
| Mu-type opioid receptor | Target Info | Inhibitor | [530529] | ||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
| Opioid prodynorphin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
| Enkephalin release | |||||
| Pathway Interaction Database | IL4-mediated signaling events | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.